XL-protein and Wacker Biotech produce a PASylated antibody fragment (Fab) with prolonged plasma half-life at more than four grams per liter culture in an E. coli expression system
High Yield with ESETEC® and PASylation®: Wacker Biotech and…
Wacker Biotech and XL-protein Sign Long-Term Cooperation Agreement to Produce PASylated Biopharmaceuticals
Munich / Freising / Jena, October 30, 2012
Wacker Biotech…
XL-protein and Wacker demonstrate high-yield production of PASylated biopharmaceuticals using ESETEC®
Munich / Jena, June 11, 2012 – Wacker Biotech and XL-protein…